Prakt. lékáren. 2010; 6(4): 182-186

Specific antifungals and their use in the therapy of selected diseases

PharmDr.Petr Horák
Nemocniční lékárna FN Motol a Katedra lékárenství IPVZ

The incidence of systemic fungal infections especially has been growing in last decades. It is related to the expansion of HIV/AIDS pandemic

and also to the development of therapy of many diseases that affect immunity. It has resulted in the development of new drugs

and new therapeutic classes, or changes in the administration and indications of formerly known drugs. Moreover, new therapeutic

approaches have also been employed in the therapy of topical mycoses, and this article is devoted to them, too.

Keywords: antifungals, systemic mycosis, topical mycosis

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horák P. Specific antifungals and their use in the therapy of selected diseases. Praktické lékárenství. 2010;6(4):182-186.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Borovanský A. Farmaceutická chemie VI. Antiinfektiva - Antimykotika, antivirotika. Brno: Farmaceutická fakulta VŠVF, 1993: 15-41.
    2. Lexi-Drugs. In: Lexi-Complete iPhone edition. [cit. 20. 4. 2010].
    3. Databáze registrovaných léčivých přípravků a PZLÚ SÚKL. Dostupné na http://www.sukl.cz/modules/medication/search.php [cit. 20. 4. 2010].
    4. Haber J. Amphotericinum B. Remedia 1994; 4(5): 274-283.
    5. Bing CM. Extended Stability for Parenteral Drugs. American Society of Health-System Pharmacists, 2005: 230 s.
    6. Sklenář Z, Hašek J. Nové léčivé přípravky v magistraliter receptuře I. - Nystatin. Prakt. lékáren. 2010; 6(1): 30-35.
    7. Helms RA (ed.). Textbook of therapeutics. 8. vyd. Lippincott Williams & Wilkins, 2006: 2172-2193 s.
    8. Automatizovaný informační systém léčivých přípravků. Mikroverze ČR, verze 2010.2, [cit. 20. 4. 2010].
    9. Sweetman SC (ed.). Martindale: The Complete Drug Reference. 36th Edition. Pharmaceutical Press, 2009: 3694 s.
    10. McEvoy GK (ed.). AHFS Drug Information 2007. American Society of Health-System Pharmacists, 2007: 3824 s.
    11. Harrison's Practice. In Lexi-Complete iPhone edition, [cit. 20. 4. 2010].
    12. Zazula R, Schindler I, Spálený A, Vašáková M, Dutka J. Současný pohled na mykotické plicní infekce. Interní medicína pro praxi 2005; 7-8: 349-353.
    13. Skořepová M. Léčba kožních mykóz. Practicus 2008; 4: 12-16.
    14. DiPiro JT (ed.). Pharmacotherapy. A Pathophysiological Approach. 6th Edition. McGraw Hill, 2005: 2802 s.
    15. Armour D, Cairns C (ed.). Medicines in the Elderly. Pharmaceutical Press, 2002: 428 s.
    16. Buchta V, Špaček J, Jílek P. Mykotické infekce ženského genitálu. Dostupné na http://www.gyne.cz/clanky/1998/298cl10.htm, [cit. 18. 4. 2010].
    17. Krämer I. Comparing echinocandins: a review. EJHP Practice, 2010; 16(2): 63-67. Go to original source...
    18. Ráčil Z, Kocmanová I, Mayer J. Micafungin - nový echinokandin. Farmakoterapie 2009; 2: 165-172.
    19. Infectious Diseases. In: Lexi-Complete iPhone edition, [cit. 20. 4. 2010].
    20. Haber J, Mallátová N. Voriconazol. Farmakoterapie 2005; 5: 443-462.
    21. Haber J, Mallátová N. Posakonazol. Remedia 2007; 17(1): 50-59.
    22. Haber J, Mallátová N. Lipidový komplex amphotericinu B - jeho role mezi ostatními antimykotiky v léčbě invazivní kandidózy. Analýza klinických studií. Remedia 2007; 17(5): 511-523. Go to original source...
    23. Mišunová L. Mykotické infekce u HIV pozitivních pacientů. Alergie 2009; 2: 141-149.
    24. Kuklová I. Mykózy kůže a nehtů. Med. pro praxi 2006; 3: 129-131.
    25. Litvik R. Lokální a systémová léčba onychomykóz - doporučení pro praxi. Remedia 2009; 19(1): 9-13.
    26. Skořepová M. Kožní mykózy a onychomykózy. Dostupné na www.cls.cz/dokumenty2/os/t239.rtf, [cit. 20. 4. 2010].

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.